Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Aug 21, 2020 9:40am

134 Views

Post# 31437678

RE:BCG & SARS‐CoV‐2

Interesting Gustoes in that report its suggested that even BCG has been administered incorrectly leading to undesirable affects to the patient so in comparison to the incorrect dosage of TLD-1433 during the phase 2 trial being less than the required dosage our outcome still performed well in 8 of the 12 patients. Also if within this report protection is suspected from BCG for the Coronavirus then yes that could cause a further shortage ... better get this clinical trial movie to warp 1

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario